Drug Shortage Report for DIASTAT
Report ID | 146703 |
Drug Identification Number | 02238162 |
Brand name | DIASTAT |
Common or Proper name | DIASTAT |
Company Name | BAUSCH HEALTH, CANADA INC. |
Market Status | MARKETED |
Active Ingredient(s) | DIAZEPAM |
Strength(s) | 5MG |
Dosage form(s) | GEL |
Route of administration | RECTAL RECTAL |
Packaging size | 10 mg 2pk |
ATC code | N05BA |
ATC description | ANXIOLYTICS |
Reason for shortage | Other (Please describe in comments) |
Anticipated start date | |
Actual start date | 2021-09-07 |
Estimated end date | 2021-10-08 |
Actual end date | 2021-10-19 |
Shortage status | Resolved |
Updated date | 2021-12-09 |
Company comments | awaiting QA release |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 2150 BOUL. ST-ELZEAR OUEST LAVAL, QUEBEC CANADA H7L 4A8 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v4 | 2021-12-09 | French | Compare |
v3 | 2021-12-09 | English | Compare |
v2 | 2021-10-05 | French | Compare |
v1 | 2021-10-05 | English | Compare |
Showing 1 to 4 of 4